PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma.

Invest Ophthalmol Vis Sci · 2023 · PMC10755595 · PMID 38149971

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

As evident from the values presented in the table, most of the cases in the D3 cohort had <5 mitoses, and the association of PRAME expression with age at enucleation and chromosome 6p gain was only borderline significant.

also in 11,409 other papers

near-significantno p-value reported

We did not find a significant correlation of PRAME with chromosome 3 status or BAP1 expression in either cohort, and we saw a borderline correlation with 6p gain in the TCGA disomy 3 subcohort and a matched near-significant correlation in the LUMC disomy 3 subcohort.

also in 2,306 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.